Open original FDA record ↗Recall record
- FDA identifier
- Z-2385-2010
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- Sep 8, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Test produces falsely elevated IBCT results and Abnormal Reaction test report messages on heparinized plasma samples.
Source facts
- Action
- Siemens issued an "Urgent Field Safety Notice" letter dated December 2009 to users identifying the issue and affected product. Customers were instructed not to use heparinized plasma samples for IBCT testing. IBCT Instructions for Use (IFU) has been updated to reflect that heparinized plasma is no longer an acceptable sample type. Beginning with lot ED0341, the new IFU will be packaged in the carton with the IBCT Flex reagent cartridges. Consignees were requested to forward the notification letter to anyone to whom the product was distributed. The Siemens Technical Solutions Center can be contacted at 800-441-9250.
- Initiated
- 2009-12-16
- Root cause
- Nonconforming Material/Component
- Terminated
- 2010-10-25
- Distribution
- Worldwide Distribution: USA (all states) and the countries of Canada, Switzerland, New Zealand, Australia, Japan, and South Korea.
- Recall number
- Z-2385-2010
- Recall status
- Terminated
- CDRH record ID
- 88527
- FDA classified
- 2010-09-08
- Recall event number
- 54460